http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8940486-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdc96bff90c27677161c60f18e2e441b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efd09c296645384c4e1c770411f7aa01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f14e25dcb8ee665c1a0e1faa5b47534
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7c5beb151f3c479e36f5b5f05a6d4b9
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
filingDate 2011-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41e6ee5b8df6166cf93acb7317b3db2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90f596c05beddee4539acfe93bb5f525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b93c09fecddd58d8028b7db563b3809
publicationDate 2015-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-8940486-B2
titleOfInvention Oligonucleotides and methods for detecting KRAS and PIK3CA mutations
abstract Provided are oligonucleotides that are capable of detecting KRAS and PIK3CA mutations in both cancer patients and healthy individuals with high specificity in kPCR assays. When the oligonucleotides are used as forward primers in conjunction with a defined genotyping algorithm spreadsheet, the primers are capable of enhancing detection of KRAS codon 12, 13, and 61 and PIK3CA codon 542, 545, and 1047 single nucleotide polymorphisms (SNPs) in a background of wild-type sequences. The oligonucleotides of the present invention are also capable of preventing pseudogene amplification when the oligonucleotides are hybridized as reverse primers or detection probes to the mismatch sequences.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018124538-A1
priorityDate 2010-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005272083-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006095981-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008305478-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012095505-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009280486-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129472015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129724918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398593

Total number of triples: 36.